Pruritus during anti-HCV treatment with PTV/r/OBV+/-DSV is associated with increased bile acid levels.
R Stauber, G Fauler, F Rainer, A Posch, A Streit, W Spindelböck, V Stadlbauer, H Mangge · Zeitschrift für Gastroenterologie · 2016 · Heft 05
Bibliografische Angaben
Zusammenfassung
Introduction: Interferon-free anti-HCV treatment with paritaprevir/ritonavir + ombitasvir +/- dasabuvir (PTV/r/OBV+/-DSV) is highly effective and well-tolerated with only minimal side effects. However, pruritus has been observed in phase III trials in up to 20% of patients and seems to be unique for this DAA combination. The aim of this study was to investigate the effect of PTV/r/OBV+/-DSV on bile acid levels and to relate them to the emergence of pruritus during this treatment. Methods: Patients with chronic hepatitis C genotype 1 or 4 were treated for 12 – 24 weeks with PTV/r/OBV+/-DSV with or without ribavir…